J9262 Omacetaxine - CanMED: HCPCS

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Medication Information

CanMED: HCPCS

Generic Name:

Omacetaxine

Brand Name:

Synribo

Strength:

0.01 mg

HCPCS:

J9262

SEER*Rx Category:

Chemotherapy

Major Drug Class:

Plant Alkaloid

Minor Drug Class:

BCR-ABL

Oral (Y/N):

No

FDA Approval Year:

2012

FDA Discontinuation Year:

CMS Effective Date:

Jan. 1, 2014

CMS Discontinuation Date:

Status:

In Use